DTP Branches and Offices
Last Updated: 07/23/15
List of Supported INDs/DMFs
Small Molecule Cancer Drugs
| Small Molecule Cancer Drugs: | NSC Number |
|---|---|
| Deoxyspergualin | (NSC 356894) |
| Cyclopentenyl Cytosine (CPEC) 3 | (NSC 375575) |
| Carboxyaminoimidazole (CAI) 3 | (NSC 609974) |
| Fostriecin, Sodium | (NSC 339638) |
| TNP-470 (Fumagillin Analog) | (NSC 642492) |
| 9-Amino[20S]camptothecin | (NSC 603071) |
| Penclomedine | (NSC 338720) |
| Bizelesin | (NSC 615291) |
| O6-Benzylguanine/BCNU (O6BG) | (NSC 637037) |
| Flavopiridol 3 | (NSC 649890) |
| Rebeccamycin Tartrate | (NSC 655649) |
| Perillyl Alcohol | (NSC 641066) |
| Tributyrin | (NSC 661583) |
| Dolastatin 10 | (NSC 376128) |
| UCN-01 3 | (NSC 638850) |
| Quinocarmycin Analog DX-52-1 | (NSC 607097) |
| KRN5500 | (NSC 650426) |
| Bizelesin (Bone Marrow) | (NSC 615291) |
| Depsipeptide NDA | (NSC 630176) |
| Penclomedine (Oral) | (NSC 338720) |
| Cordycepin/Deoxycoformycin | (NSC 63984/218321) |
| Ecteinascidin 743 | (NSC 648766) |
| COL-3 | (NSC 683551) |
| EF-5 | (NSC 684681) |
| PS-341 NDA | (NSC 681239) |
| G3139 | (NSC 683428) |
| SarCNU | (NSC 364432) |
| 17-Allylaminogeldanamycin | (NSC 330507) |
| Pc-4 (Silicone Phthalocyanine) | (NSC 676418) DMF |
| PS-341 (Velcade) NDA | (NSC 681239) |
| G3139 | (NSC 683428) |
| Tempol 3 | (NSC 142784) |
| 2-Methoxyestradiol | (NSC 659853) |
| Pyroxamide | (NSC 696085) DMF |
| Benzoylphenylurea | (NSC 639829) |
| MS-275 | (NSC 706995) |
| 2-Methoxyestradiol | (NSC 659853) |
| Epothilone D (KOS-862) 10 | (NSC 703147) |
| R-(+)-XK-469 | (NSC 698215) |
| Eisai Compound E7389 | (NSC 707389) |
| Imexon 10 | (NSC 714597) |
| PT-523 10 | (NSC 633713) |
| 8-Chloroadenosine 10 | (NSC 354258) |
| Cytochlor/THU | (NSC 371331+112907) |
| Betulinic Acid (Dermal) 10 | (NSC 113090) |
| Tetrathiomolybdate (TTM) 10 | (NSC 714598) |
| Safingol 10 | (NSC 714503) |
| Buthionine Sulfoximine (BSO) 10 | (NSC 326231) |
| 17-Dimethylaminogeldanamycin | (NSC 707545) |
| Fenretinide iv Formulation 10 | (NSC 374551) |
| Pyrrolobenzodiazepine dimer | (NSC 694501) |
| 5-Iodo-2-pyrimidinone-2'-deoxyribose (IpdR) 10 | (NSC 726188) |
| Fluorodeoxycytidine + THU 10 | (NSC 48,006+112907) |
| Methoxyamine + Temozolomide 10 | (NSC 3801+362856) |
| MAP Regimen (MMPR + 6-AN + PALA) 10 | (NSC 40774+21206+224131) |
| 4-HPR Lym-X-Sorb Oral Form 10 | (NSC 374551) |
| 4-HPR + Safingol 10 | (NSC 374551+714503) |
| 18F-EF5 and EF5 | (NSC 734904) |
| PXD-101 | (NSC 726630) |
| Aminoflavone | (NSC 710464) |
| MLN518 (Tandutinib) | (NSC 726292) |
| CDDO 10 | (NSC 711136) |
| ABT-888 37,44 | (NSC 737664) |
| DB-67 10 | (NSC 708298) |
| Batracylin | (NSC 320846) |
| AT-101 (Gossypol) 10 | (NSC 726190) |
| ABT-888/Topotecan Combination 44 | (NSC 737664) |
| 1-Methyltryptophan | (NSC 721782) |
| FAU | (NSC 678515) |
| Dimethane Sulfonate 3 | (NSC 281612) |
| FdC/THU 44 | (NSC 48006+112907) |
| Indenoisoquinolines 44 | (NSC743400&725776) |
| TdCyd | (NSC 764276) |
| Endoxifen | (NSC 749798) |
| LUM015 | (NSC D77650) |
| NIR Flurophore ZW800 | (NSC D772596-M) |
Biological Cancer Agents
| Biological Cancer Agents: | NSC Number |
|---|---|
| LMB-1 [B3-NLysPE38] 3 | (NSC 651311) |
| r-V-CEA(180k) 3 | (NSC 649024) |
| r-V-MAGE1 3 | (NSC 658894) |
| LMB-7 [B3-(Fv)PE38] 3 | (NSC 658931) |
| MART-1 Peptide/ISA 3 | (NSC 672643) |
| PCLUS 3-18MN, 6.1-18MN, P-18MN/ISA [HIV]3 | (NSC 658895, 663850) |
| ras 5-17 Peptides C12, V12, D12 /Detox 3 | (NSC 667937/665824/667938) |
| r-V-CEA(70k) 3 | (NSC 649203) |
| ras Proteins (C12, D12, V12)/QS21 3 | (NSC 674779/674780/674781) |
| r-Ad2-MART-1 3 | (NSC 674304) |
| r-Ad2-gp100 3 | (NSC 674305) |
| LMB-2 [Anti-Tac(Fv)-PE38] 3 | (NSC 676422) |
| r-V-PSA 3 | (NSC 659642) |
| LMB-7 (Intrathecal Protocol) 3 | (NSC 658931) |
| r-V-B7.1 3 | (NSC 674306) |
| erb-38 [e23(dsFv)PE38] 3 | (NSC 683039) |
| LMB-9 [B39dsFv)PE38] 3 | (NSC 691236) |
| BL22 [RFB4(dsFv)PE38] 3 | (NSC 691237) |
| Endostatin | (NSC 704805) |
| Endostatin | (NSC 704805) |
| IL-12 + IL-2 3 | (NSCs 672423 & 373364) |
| Angiostatin | (NSC 703940) |
| r-V-CEA/TRICOM + r-F-CEA/TRICOM 3 | (NSCs 710067 & 710068) |
| r-V-TRICOM + r-F-TRICOM 3 | (NSCs 708039 & 710658) |
| 7G7 Monoclonal Antibody 3 | (Waldmann) |
| hsp70 E7 r-DNA Vaccine 10 | (NSC 723254) |
| Chimeric E7/HSP70 DNA Vaccine 10 | (NSC 723254/5) |
| VH4-34 Monocolonal Antibody 10 | (NSC 711294) |
| MR1-1 Immunotoxin (dsvPE38KDEL) 10 | (NSC 718877) |
| EGFRvIII Peptide Vaccine 10 | (NSC 710294) |
| pING-TRYP2 10 | (NSC 723254) |
| MV-NIS | (NSC 731414) |
| CMV Lipopeptide Vaccines 10 | (NSCs 721433 & 721434) |
| Ad5-Delta24-RGD 10 | (NSC 723256) |
| Reolysin (Reovirus SeroType3) | (NSC 729968) |
| Multiple Myeloma Vaccine (U266/H929) 10 | (NSC 723253) |
| IL-6 10 | (NSC 720836) |
| phAFP + phGM-CSF Plasmid + AdVhAFP 10 | (NSC 725180/1/2) |
| Ad5.SSTR/TK.RDG 10 |
AIDS DRUGS
| AIDS DRUGS: | NSC Number |
|---|---|
| Dideoxycytidine (ddC) 3 NDA | (NSC 606170) |
| Dideoxyadenosine (ddA) 3 | (NSC 98700) |
| Dideoxyinosine (ddI) 3 NDA | (NSC 612049) |
| 3TC [In Part] NDA | (NSC 620753) |
| A-77003 (Protease Inhibitor) | (NSC 640441) |
| KNI-272 (Protease Inhibitor) 3 | (NSC 651714) |
| F-ddA 3 | (NSC 613792) |
| Isis 5320 | (NSC 665353) |
| (+)-Calanolide A | (NSC 650886) |
OTHER AGENTS
| OTHER AGENTS: | NSC Number |
|---|---|
| FP-TZTP (PET No. 01) 3 | N/A |
| MeFBAWAY (PET No. 02) 3 | N/A |
| FCWAY (PET No. 03) 3 | N/A |
| 18F-Paclitaxel (PET No. 04) 3 | N/A |
| FPWAY (PET No. 05) 3 | N/A |
| 18Fluorocholine 32 | (NSC 720948) |
| Antalarmin 3 | (NIMH) |
| Ethambutol Analog (SQ109) 35 | (NSC 722041) |
| 18F -ACBC 32 | (NSC 726817) |
| 64CuATSM 32 | (NSC 729307) |
| 18F -Galacto-RGD 32 | (NSC 729490) |
| 111Indium-CHX-AÓ DTPA Trastuzumab 44 | (NSC 740377) |
| Sodium 2,2-Dimethylbutyrate (ST20) 42 | (NSC 741804) |
| CDD-0102 42 | (NSC 743016) |
| A0001 42 | (NSC 742681) |
About the Branch Chief
Dr. Elizabeth Glaze earned her Ph.D. in Pharmacology from the University of Michigan in 1999. There she evaluated the mechanism by which 5’-bromo-2’-deoxyuridine (BrdU) sensitizes human glioma cells to DNA alkylating agents. More…